Navigation Links
Novogen Announces Presentation at Rodman & Renshaw 16th Annual Healthcare Conference
Date:9/3/2014

SYDNEY, Sept. 3, 2014 /PRNewswire/ -- Novogen Ltd. (ASX: NRT, NASDAQ: NVGN) today announced that Graham Kelly PhD, CEO, will present at the Rodman & Renshaw 16th Annual Healthcare Conference on Wednesday, September 10th in New York.  Dr. Kelly will provide an overview of the two Novogen first-in-class drug technology platforms in the field of oncology.  His presentation will take place at the New York Palace Hotel and will begin at 10:25am.

About Novogen LimitedNovogen is a public, Australian drug-development company whose shares trade on both the Australian Securities Exchange ('NRT') and NASDAQ ('NVGN'). The Novogen Group includes a New Haven CT-based joint venture company, CanTx Inc, with Yale University.

Novogen has two main drug technology platforms: super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). SBP compounds have been created to kill the full range of cells within a tumor, but particularly the cancer stem cells. The ATM compounds target the microfilament component of the cancer cell and when used in conjunction with standard anti-microtubular drugs, result in comprehensive and fatal destruction of the cancer cell's cytoskeleton. Ovarian cancer, colorectal cancer, malignant ascites, prostate cancer, neural cancers (glioblastoma, neuroblastoma) and melanoma are the key clinical indications being pursued, with the ultimate objective of employing both technologies as a unified approach to first-line therapy.

Further information is available on the Company's website, www.novogen.com.

For more information please contact:Corporate ContactMedia enquiriesExecutive Chairman & CEO
Novogen Group
Graham.Kelly@novogen.com 
+61 (0) 2 9472 4100In the USA:Lazar Partners
Novogen@lazarpartners.com 
+1 212-867-1762Investors enquiriesIn Australia:In the USA:Lazar Partners

Novogen@lazarpartners.com

+1 212-867-1762

Dr. Douglas Pretsell

Instinctif Partners

+61 (0) 3 9657 0706In ROW:Sue Charles

Instinctif Partners

+44 (0) 20 7457 2020Logo - http://photos.prnewswire.com/prnh/20131220/NY36990LOGO 


'/>"/>
SOURCE Novogen Ltd.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Novogen Announces Results of General Meeting of Shareholders
2. Novogen Receives Funding Support To Commence Studies In Muscular Dystrophy
3. Top Active Companies to Watch: Crown Marketing, Herbalife, Novogen, GNC, Pfizer and Infinity Pharmaceuticals
4. Novogen Announces Merger Agreement With Kai Medical And Distribution Of Mei Pharma Shares
5. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
6. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
7. Ascendant Solutions, Inc. Announces Completion of Second Pharmacy Acquisition by Its Doughertys Holdings Subsidiary
8. Integrity Applications, Inc. Announces Equity Financing of $3.0 Million
9. GenSpera Announces Generic Name "Mipsagargin" for Lead Drug Candidate G-202 per Recommendation by World Health Organization
10. Cepheid Announces European Release of Xpert TV, a Next-Generation Molecular Test for Rapid and Accurate Identification of Trichomonas vaginalis Infections
11. MarketResearch.com Announces Addition of New Kalorama Information Content to Diagnostics Knowledge Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017  Genesis Healthcare Services has merged with Hospice ... by Bill Monast , President and CEO of ... Nathan Feltman , executives with Home Health Depot, Inc., ... This acquisition helps Hospice Cloud maintain its ... durable medical equipment (DME) solutions for the hospice industry. ...
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... - 2016" report to their offering. ... The latest research Fibromyalgia Drugs Price ... in the global Fibromyalgia market. The research answers the ... marketed for Fibromyalgia and their clinical attributes? How are they positioned ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President and CEO ... year. Dyer started as the Chairman of the Management Committee when IFN was ... corporation including the recruitment of investor/owners and development of the business plan. He ...
(Date:2/24/2017)... CA (PRWEB) , ... February 24, 2017 , ... ... for qualifying into the Senior International Elite division on February 12th. Ms. ... Around divisions at the elite qualifier competition held in Las Vegas, Nevada. Frida ...
(Date:2/23/2017)... ... February 23, 2017 , ... On February ... a letter to withdraw previous guidance issued by the Obama Administration ... guidance issued in May 2016 by the Obama Administration came in response to ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... media outlet with a clinician-based audience, will be participating in Rare Disease Day ... in Washington, D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and ...
(Date:2/23/2017)... ... , ... Hamlin Dental Group and Dr. Hamid Reza, dentist in North ... month of February, patients who visit Hamlin Dental Group will receive a ticket for ... at the Cheesecake Factory. , Tickets are available for routine dental visits and ...
Breaking Medicine News(10 mins):